JAZZ
Jazz Pharmaceuticals PLC
NASDAQ: JAZZ · HEALTHCARE · BIOTECHNOLOGY
$199.92
-1.99% today
Updated 2026-04-29
Market cap
$12.54B
P/E ratio
—
P/S ratio
2.94x
EPS (TTM)
$-5.83
Dividend yield
—
52W range
$98 – $207
Volume
1.0M
Jazz Pharmaceuticals PLC (JAZZ) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $44.86M | $65.30M | $67.51M | $128.45M | $173.78M | $272.28M | $585.98M | $872.42M | $1.17B | $1.32B | $1.49B | $1.62B | $1.89B | $2.16B | $2.36B | $3.09B | $3.66B | $3.83B | $4.07B | $4.27B |
| Revenue growth (YoY) | — | +45.6% | +3.4% | +90.3% | +35.3% | +56.7% | +115.2% | +48.9% | +34.4% | +13.0% | +12.3% | +8.8% | +16.8% | +14.3% | +9.3% | +30.9% | +18.3% | +4.8% | +6.1% | +4.9% |
| Cost of revenue | $6.97M | $8.90M | $13.92M | $9.64M | $13.56M | $13.94M | $78.42M | $102.15M | $117.42M | $102.53M | $105.39M | $110.19M | $121.54M | $127.93M | $148.92M | $440.76M | $540.52M | $435.58M | $445.71M | $503.30M |
| Gross profit | $37.89M | $56.40M | $53.59M | $118.81M | $160.22M | $258.33M | $507.55M | $770.28M | $1.06B | $1.22B | $1.38B | $1.51B | $1.77B | $2.03B | $2.21B | $2.65B | $3.12B | $3.40B | $3.62B | $3.76B |
| Gross margin | 84.5% | 86.4% | 79.4% | 92.5% | 92.2% | 94.9% | 86.6% | 88.3% | 90.0% | 92.3% | 92.9% | 93.2% | 93.6% | 94.1% | 93.7% | 85.8% | 85.2% | 88.6% | 89.0% | 88.2% |
| R&D | $54.96M | $69.79M | $69.96M | $36.56M | $25.61M | $14.12M | $20.48M | $46.62M | $85.18M | $135.25M | $162.30M | $198.44M | $226.62M | $299.73M | $335.38M | $505.75M | $590.45M | $849.66M | $884.00M | $782.74M |
| SG&A | $106.34M | $78.50M | $111.40M | $58.70M | $69.00M | $108.90M | $223.18M | $303.30M | $380.41M | $447.48M | $501.38M | $544.14M | $683.53M | $736.94M | $854.23M | $1.45B | $1.42B | $1.33B | $1.39B | $1.81B |
| Operating income | $-78.05M | $-138.78M | $-170.37M | $15.93M | $57.79M | $127.83M | $197.84M | $340.31M | $195.59M | $508.22M | $591.65M | $528.84M | $614.84M | $532.37M | $378.07M | $170.28M | $-65.53M | $578.58M | $716.63M | $224.42M |
| Operating margin | -174.0% | -212.5% | -252.3% | 12.4% | 33.3% | 46.9% | 33.8% | 39.0% | 16.7% | 38.4% | 39.8% | 32.7% | 32.5% | 24.6% | 16.0% | 5.5% | -1.8% | 15.1% | 17.6% | 5.3% |
| EBITDA | $-67.74M | $-128.25M | $-125.58M | $25.03M | $54.21M | $134.41M | $310.18M | $454.11M | $583.70M | $665.97M | $753.88M | $779.00M | $932.66M | $1.01B | $1.04B | $1.03B | $1.47B | $1.45B | $1.52B | $108.46M |
| EBITDA margin | -151.0% | -196.4% | -186.0% | 19.5% | 31.2% | 49.4% | 52.9% | 52.1% | 49.8% | 50.3% | 50.7% | 48.1% | 49.3% | 46.8% | 44.2% | 33.2% | 40.1% | 37.8% | 37.4% | 2.5% |
| EBIT | $-78.05M | $-138.78M | $-140.60M | $15.93M | $45.50M | $126.58M | $235.95M | $372.02M | $450.02M | $557.91M | $640.10M | $613.84M | $715.93M | $642.35M | $765.46M | $475.26M | $839.14M | $810.73M | $861.64M | $-433.54M |
| Interest expense | $0.00 | $13.65M | $19.74M | $22.80M | $12.73M | $1.68M | $16.87M | $26.92M | $52.71M | $56.92M | $61.94M | $77.76M | $78.50M | $72.26M | $99.71M | $278.77M | $288.24M | $289.44M | $238.10M | $195.05M |
| Income tax | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Effective tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | $-59.39M | $-138.83M | $-184.34M | $-6.84M | $32.78M | $124.98M | $288.59M | $216.31M | $58.39M | $329.54M | $396.83M | $487.85M | $447.10M | $523.37M | $238.62M | $-328.95M | $-224.06M | $414.83M | $560.12M | $-356.15M |
| Net income growth (YoY) | — | -133.7% | -32.8% | +96.3% | +579.5% | +281.3% | +130.9% | -25.0% | -73.0% | +464.4% | +20.4% | +22.9% | -8.4% | +17.1% | -54.4% | -237.9% | +31.9% | +285.1% | +35.0% | -163.6% |
| Profit margin | -132.4% | -212.6% | -273.0% | -5.3% | 18.9% | 45.9% | 49.2% | 24.8% | 5.0% | 24.9% | 26.7% | 30.1% | 23.6% | 24.2% | 10.1% | -10.6% | -6.1% | 10.8% | 13.8% | -8.3% |